Literature DB >> 20698045

Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes.

Nozomu Sakai1, Callisia N Clarke, Rebecca Schuster, John Blanchard, Amit D Tevar, Michael J Edwards, Alex B Lentsch.   

Abstract

AIM: To investigate the mechanisms of liver growth and atrophy after portal vein ligation (PVL) and its effects on tumor growth.
METHODS: Mice were subjected to PVL, partial hepatectomy, or sham surgery. The morphological alterations, activation of transcription factors, and expression of cytokines and growth factors involved in liver regeneration were evaluated. In a separate set of experiments, murine colorectal carcinoma cells were injected via the portal vein and the effect of each operation on liver tumor growth was studied.
RESULTS: Liver regeneration after PVL and partial hepatectomy were very similar. In ligated lobes, various cytokines, transcription factors and regulatory factors were significantly upregulated compared to non-ligated lobes after PVL. Atrophy in ligated lobes was a result of early necrosis followed by later apoptosis. Tumor growth was significantly accelerated in ligated compared to non-ligated lobes.
CONCLUSION: Tumor growth was accelerated in ligated liver lobes and appeared to be a result of increased growth factor expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698045      PMCID: PMC2921094          DOI: 10.3748/wjg.v16.i30.3816

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

Review 1.  Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review.

Authors:  Y Yokoyama; M Nagino; Y Nimura
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

2.  A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues.

Authors:  F Deryckere; F Gannon
Journal:  Biotechniques       Date:  1994-03       Impact factor: 1.993

3.  Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis.

Authors:  B Rocheleau; C Ethier; R Houle; P M Huet; M Bilodeau
Journal:  Am J Physiol       Date:  1999-11

4.  Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume.

Authors:  K Shirabe; M Shimada; T Gion; H Hasegawa; K Takenaka; T Utsunomiya; K Sugimachi
Journal:  J Am Coll Surg       Date:  1999-03       Impact factor: 6.113

5.  Mechanical stress-dependent secretion of interleukin 6 by endothelial cells after portal vein embolization: clinical and experimental studies.

Authors:  Masami Kawai; Keiji Naruse; Shunichiro Komatsu; Satoshi Kobayashi; Masato Nagino; Yuji Nimura; Masahiro Sokabe
Journal:  J Hepatol       Date:  2002-08       Impact factor: 25.083

6.  Cyclin expression in the atrophying and proliferating lobes of the liver after portal vein branch ligation and hepatectomy in rats.

Authors:  Junji Ueda; Kazuo Chijiiwa; Kenji Nakano
Journal:  J Surg Res       Date:  2004-07       Impact factor: 2.192

7.  Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization.

Authors:  S Hayashi; Y Baba; K Ueno; M Nakajo; F Kubo; S Ueno; T Aikou; T Komokata; N Nakamura; R Sakata
Journal:  Acta Radiol       Date:  2007-09       Impact factor: 1.990

8.  Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.

Authors:  Y Yamada; E M Webber; I Kirillova; J J Peschon; N Fausto
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

9.  Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.

Authors:  Martin Palavecino; Yun S Chun; David C Madoff; Daria Zorzi; Yoji Kishi; Ahmed O Kaseb; Steven A Curley; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2009-04       Impact factor: 3.982

10.  c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity.

Authors:  Ewa Stepniak; Romeo Ricci; Robert Eferl; Grzegorz Sumara; Izabela Sumara; Martina Rath; Lijian Hui; Erwin F Wagner
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

View more
  4 in total

1.  Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth.

Authors:  Sebastian Senger; Jens Sperling; Barbara Oberkircher; Martin K Schilling; Otto Kollmar; Michael D Menger; Christian Ziemann
Journal:  Clin Exp Metastasis       Date:  2017-06-19       Impact factor: 5.150

2.  Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the mTOR-inhibitor temsirolimus after portal branch ligation.

Authors:  Jens Sperling; Christian Ziemann; Anika Gittler; Anna Benz-Weißer; Michael D Menger; Otto Kollmar
Journal:  Clin Exp Metastasis       Date:  2015-02-19       Impact factor: 5.150

Review 3.  Tumour progression and liver regeneration--insights from animal models.

Authors:  Chetana Lim; Francois Cauchy; Daniel Azoulay; Olivier Farges; Maxime Ronot; Marc Pocard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-09       Impact factor: 46.802

4.  Effect of portal vein ligation on tumor growth and liver regeneration in rat cirrhotic liver lobes.

Authors:  Rui Xu; Yu-Feng Yuan; Ahmet Ayav; Chong-Qing Jiang; Laurent Bresler; Zhi-Su Liu; Nguyen Tran
Journal:  Exp Ther Med       Date:  2014-03-06       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.